Searched for
BAYER DEAL
Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities ended lower, snapping a two-day rally as escalating Iran-US tensions and profit booking weighed on sentiment. Sensex fell 3...- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian markets rallied on Wednesday, with Sensex and Nifty gaining up to 1% amid easing crude prices, supportive global cues and optimism o...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities advanced for a fourth straight session as easing geopolitical tensions, lower crude oil prices, softer bond yields and a st...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities extended gains for a third straight session, with Sensex and Nifty rising on optimism over the Iran-US peace framework and ...
- El Niño needs monitoring, but India better prepared than earlier: Bayer’s Simon WiebuschFarmers are increasingly recognising climate volatility as a long-term reality, driving greater adoption of climate-smart practices, says S...
- India won't have to rely on foreign suppliers for new-gen refrigerant gases, says SRF's Ashish Bharat RamThe new refrigerants called hydrofluoroolefins, or HFOs, are quickly replacing older hydrofluorocarbons, or HFCs, in the USA and Europe as ...
- Bayer to buy Perfuse Therapeutics in up to $2.45 billion dealBayer is set to acquire Perfuse Therapeutics in a deal valued up to $2.45 billion. This strategic move aims to enhance Bayer's eye care tre...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Amazon signs $30 million deal to buy carbon credits from Indian rice farmersAmazon has signed a $30 million (around ₹280 crore) agreement with the Good Rice Alliance, backed by Bayer, Temasek’s GenZero and Shell, to...
- Will Bayer's proposed $7.25 billion Roundup deal bring legal closure?Bayer's Monsanto division is making headlines with a bold offer of $7.25 billion to settle lawsuits concerning Roundup and its alleged link...
- Bayer launches $7 billion cash call to fund Monsanto dealBayer last week won U.S. approval for the Monsanto takeover, clearing a major hurdle for a deal that will create by far the largest seeds a...
- Bayer sees delays, expects to close $66-billion Monsanto deal by early 2018Bayer had in September 2016 agreed to take over Monsanto for USD 66 billion, ending months of wrangling with a third sweetened offer that m...
- How this $66 billion deal turned ‘oracle’ Warren Buffett into an arbitragerWe don't know for sure if it was Buffett himself or one of his stock-picking deputies who made the investment. Either way, he no doubt gave...
- IP our cornerstone; innovation can help farmers, says BayerIn India, Bayer offers GM technonly in Bt cotton. In seeds business, its focus in India is in vegetable seeds, but it does not see markets ...
- Bayer bullish on India, but Monsanto’s image remains a challengeBayer’s Indian operations already include a crop science segment, which is involved in crop protection, seeds and what it calls “digital fa...
- Bayer to acquire Monsanto for $66 billion all-cash dealBoth Bayer and Monsanto have presence in India with the US firm selling genetically modified (GM) cotton seeds in the country for more than...
- Germany’s Bayer exploring takeover bid for MonsantoThe German firm has held preliminary discussions internally and with advisers about buying Monsanto, which has a market value of almost $40...
- Bayer set to sell off Powai HQ for over Rs 90 croreLocated a stone’s throw from the Colgate headquarters, the six-storey building’s sale, to be finalized soon, is estimated to fetch Bayer ov...
- Zydus Cadila in talks to market Bayer drugsAhmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...
- Merck hikes Schering stake, threatens BayerGerman drugs and chemicals group Merck has raised its holding in rival Schering to just over 10%, threatening a planned takeover of Scherin...
Load More
